LPN IV Push Medications - PowerPoint PPT Presentation

About This Presentation
Title:

LPN IV Push Medications

Description:

Inhibits chemoreceptor triggers in the medulla and alters the dopamine effects by ... obstructive sleep apnea, ... sleep apnea, coma Precautions: cardiovascular ... – PowerPoint PPT presentation

Number of Views:72
Avg rating:3.0/5.0
Slides: 69
Provided by: bsh50
Category:

less

Transcript and Presenter's Notes

Title: LPN IV Push Medications


1
LPN IV Push Medications
  • Part 2
  • April 2010

2
Additional IV Push Medications
  • Ativan
  • Decadron
  • Digoxin
  • Phenergan
  • Robinul
  • Solumedrol
  • Valium

3
Ativan (Lorazepam)
  • Class Benzodiazepine, Anxiolytic
  • Action Thought to depress CNS at limbic system
    and disrupt neurotransmission in reticular
    activating system
  • Availability Injection- 2 mg/ml, 4 mg/ml
    Tablets- 0.5 mg, 1 mg, 2 mg

4
Ativan, cont.
  • Indications dosage
  • Anxiety- 2-3 mg PO daily in two or three
    divided doses. Maximum dosage is 10 mg daily.
  • Insomnia- 2-4 mg PO at bedtime
  • Pre-Op- 0.05 mg/kg not to exceed 4 mg deep IM 2
    hours prior to surgery OR 0.044 mg/kg not to
    exceed 2 mg IV 15-20 min. prior to surgery
  • Status epilepticus- 4 mg IV given slowly- no
    faster than 2 mg per min., Can repeat if seizures
    recur after 10-15 min. Dont exceed 8 mg in 12
    hours.

5
Ativan, cont.
  • Dosage adjustment required in elderly or
    debilitated patients
  • Off label uses acute alcohol withdrawal syndrome
  • Contraindications hypersensitivity to drug,
    other benzodiazepines, polyethylene or propylene
    glycol, or benzyl alcohol, acute angle glaucoma,
    coma, CNS depression, hepatic or renal failure

6
Ativan, cont.
  • Precautions Use cautiously in renal or hepatic
    impairment, history of suicide attempt, drug
    abuse, depressive disorder, or psychosis, elderly
    patients, pregnant or breastfeeding patients
  • Administration Dilute IV doses with equal volume
    of diluent such as NS or D5W. Give each 2 mg
    dose IV slow push over 2-5 minutes. Dont exceed
    rate of 2 mg/min.

7
Ativan, cont.
  • Adverse Reactions amnesia, agitation, ataxia,
    depression, disorientation, dizziness,
    drowsiness, headache, incoordination, asthenia,
    hypotension with too rapid administration IV,
    bradycardia, tachycardia, apnea, cardiac arrest,
    blurred vision, diplopia, nystagmus, nausea,
    abdominal discomfort

8
Ativan, cont.
  • Interactions
  • Drug to drug additive effects with other
    benzodiazepines
  • Contraceptives increased ativan clearance
  • Drug to Herbs increased CNS depression with
    chamomile, hops, kava, skullcap, valerian
  • Drug-behaviors increased CNS depression with
    alcohol, increased metabolism and decreased
    efficacy of ativan with smoking

9
Ativan, cont.
  • Patient monitoring
  • During IV administration, monitor
    EKG/cardiovascular and respiratory status
  • Monitor V.S. closely
  • Evaluate for amnesia
  • Watch closely for CNS depression, signs
    symptoms of overdose
  • Monitor LFTs CBC

10
Decadron (Dexamethasone)
  • Class Glucocorticoid, anti-inflammatory
  • Action reduces inflammation by suppressing
    polymorphonuclear leukocyte migration, reversing
    increased capillary permeability, and stabilizing
    leukocyte lysosomal membranes. Also suppresses
    immune response (by lymphatic activity),
    stimulate bone marrow, and promotes protein, fat,
    and carbohydrate metabolism

11
Decadron, cont.
  • Availability
  • Elixir 0.5mg/5 ml
  • Oral solution 0.5 mg/5 ml, 1 mg/ml
  • IV 4 mg/ml, 10 mg/ml, 20 mg/ml, 24 mg/ml
  • Tablets 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg,
    2 mg, 4 mg, 6 mg

12
Decadron, cont.
  • Indications Dosages
  • Allergic and inflammatory conditions-
  • 0.75- 9 mg/day PO as a single dose or in divided
    doses, in severe cases much higher doses may be
    required
  • Cerebral edema-
  • initially 10 mg IV followed by 4 mg IM every 6
    hours, then reduce dosage gradually over 5-7 days
  • Cushings syndrome-
  • 1 mg PO at 11 pm or 0.5 mg PO every 6 hours for
    48 hours (with urine collection testing as
    ordered)

13
Decadron, cont.
  • Off-label uses
  • -acute altitude sickness
  • -bacterial meningitis
  • -bronchopulmonary dysplasia in
  • preterm infants
  • -hirsutism
  • -suppression test for detection, diagnosis,
  • or management of depression

14
Decadron, cont.
  • Contraindications
  • Hypersensitivity to drug, benzyl alcohol,
    bisulfites, EDTA, creatinine, polysorbate 80, or
    methylparaben
  • Systemic fungal infections

15
Decadron, cont.
  • Precautions
  • Use cautiously in
  • renal insufficiency, cirrhosis, diabetes,
    diverticulitis, GI disease, cardiovascular
    disease, hypoprothrombinemia, hypothyroidism,
    myasthenia gravis, glaucoma, osteoporosis,
    infections, underlying immunosuppression,
    psychotic tendencies, pregnant or breastfeeding
    patients, children

16
Decadron, cont.
  • Administration
  • Give PO dose with food or milk
  • When giving IM, inject deep into gluteal muscle,
    rotate sites as needed
  • For IV use may give undiluted as single dose
    over 1 minute

17
Decadron, cont.
  • Adverse reactions
  • headache, malaise, vertigo, psychiatric
    disturbances, increased ICP, seizures,
    hypotension, thrombophlebitis, myocardial rupture
    after recent MI, thromboembolism, cataracts,
    nausea, vomiting, abdominal distetion, dry mouth,
    anorexia, peptic ulcer, bowel perforation,
    pancreatitis, ulcerative esophagitis,
    hyperglycemia, cushingoid appearance, fluid
    retention, adrenal suppression, hypokalemic
    alkalosis, muscle wasting, muscle pain,
    osteoporosis, tendon rupture, long bone
    fractures, diaphoresis, angioedema, erythema,
    rash, pruritis, acne, decreased wound healing,
    bruising, fragile skin, weight gain or loss,
    increased susceptability to infections

18
Decadron, cont.
  • Interactions
  • Drug to drug barbiturates, phenytoin, rifampin-
    decreased
  • decadron effects
  • Digoxin- increases risk of dig toxicity
  • Ephedrine- increased decadron clearance
  • Contraceptives- block decadron absorption
  • Fluoroquinolones- increased risk of tendon
    rupture
  • Ketoconazole, itraconazole- increased decadron
    level
  • and effects
  • Live-virus vaccines- decreased antibody
    response to
  • vaccine
  • Loop thiazide diuretics- additive hypokalemia
  • NSAIDs- increased risk of GI effects
  • Somatrem, somatropin- decreased response to
    these
  • drugs

19
Decadron, cont.
  • Drug-Diagnostic tests- calcium potassium-
    levels decreased, cholesterol glucose- levels
    increased
  • Drug-Herbs- echinacea- increased
    immune-stimulating effect, ginseng potentiation
    of immune-modulating response
  • Drug-behaviors alcohol use- increased gastric
    irritation GI ulcers

20
Digoxin (lanoxin)
  • Class cardiac glycoside, inotrope,
    antiarrhythmic
  • Action increases force and velocity of
    myocardial contraction and prolongs refractory
    period of AV node by increasing calcium entry
    into myocardial cells. Slows conduction through
    SA and AV nodes and produces antiarrhythmic
    effects

21
Digoxin, cont.
  • Availability
  • Capsules 0.05 mg, 0.1 mg, 0.2 mg
  • Tablets 0.125 mg. 0.25 mg, 0.5 mg
  • Elixir (pediatric) 0.05 mg/ml
  • IV 0.05 mg/ml, 0.1 mg/ml, 0.25 mg/ml

22
Digoxin, cont.
  • Indications and dosage
  • Heart failure, tachyarrhythmias, atrial
    fib/flutter, PSAT
  • LPNs will only be giving this drug for
    maintenance dosing. LPNs will NOT be pushing
    this drug for initial digitializing of the
    patient.

23
Digoxin, cont.
  • Dosage adjustment renal impairment,
    hyperthyroidism, elderly patients
  • Off-label uses SVT, intrauterine tachycardias
  • Contraindications hypersensitivity to drug,
    uncontrolled ventricular tachycardias, AV block,
    idiopathic hypertrophic subaortic stenosis,
    constrictive pericarditis
  • Precautions renal or hepatic impairment,
    electrolyte imbalances, myocardial infarction,
    thyroid disorders, obesity, elderly patients,
    pregnant or breastfeeding patients

24
Digoxin, cont.
  • Administration
  • Measure apical pulse for one full minute before
    administering. If rate is below 60 bpm, withhold
    dose and notify provider.
  • Drug has narrow therapeutic index, monitor
    patient carefully for toxicity

25
Digoxin, cont.
  • Adverse reactions fatigue, headache, asthenia,
    bradycardia, EKG changes, arrhythmias, blurred or
    yellow vision, nausea, vomiting, diarrhea,
    gynecomastia, thrombocytopenia, decreased
    appetite.

26
Digoxin, cont.
  • Interactions
  • Drug-drug many drugs result in changes in
    digoxin blood level possibly leading to toxicity,
    check nursing drug resources for a complete list
    partial list includes amiodarone, cyclosporine,
    diclofenac, diltiazem, propafenone, quinidine,
    quinine, verapamil, amphotericin B,
    corticosteroids, mezlocillin, pipercillin,
    thiazide and loop diuretics, ticarfillin,
    antacids, cholestyramine, colestipol,
    kaolin/pectin, beta blockers, laxatives,
    spironalactone, thyroid hormones
  • Drug-herb cocoa seed, coffee seed, cola seed,
    guarana seed, horsetail, licorice, aloe, yerba
    mate, may lead to toxicity

27
Digoxin, cont.
  • Therapeutic range for digoxin blood levels is 0.5
    to 2.0 ng/ml

28
Phenergan
  • Promethazine
  • Nonselective phenothiazine
  • Antihistamine, antiemetic, sediative-hypnotic
  • Black box warning dont use suppositories in
    patients under the age of 2 due to potential for
    fatal respiratory depression

29
Phenergan, cont.
  • Action- blocks effects but not release of
    histamine and exerts strong alpha-adrenergic
    effects. Inhibits chemoreceptor triggers in the
    medulla and alters the dopamine effects by
    indirectly reducing stimulation in CNS
  • Availability
  • Injection 25 mg/ml, 50 mg/ml
  • Suppositories 12.5 mg, 25 mg, 50 mg
  • Syrup 6.25/5ml
  • Tablets 12.5 mg, 25 mg, 50 mg

30
Phenergan, cont.
  • Indications Type 1 hypersensitivity reaction,
    nausea, motion sickness, sedation
  • Dosages Adults- 25-50 mg PO, PR, IM or IV q4-6
    hours prn
  • At City, IV doses are limited to 12.5 mg IV push
    diluted in 10 ml NS administered through the port
    farthest from the patient over several minutes.
    Phenergan should not be administered through a
    saline lock. IV fluids must be infusing.

31
Phenergan, cont.
  • Contraindications hypersensitivity, previous
    idiosyncratic reaction to phenothiazines, asthma,
    COPD, obstructive sleep apnea, coma
  • Precautions cardiovascular or hepatic disease,
    seizures, bone marrow depression, narrow angle
    glaucoma, prostatic hypertrophy, stenosing peptic
    ulcer, pyloroduodenal or bladder neck
    obstruction, CNS depression, pregnant or
    breastfeeding patients, children under age 2

32
Phenergan, cont.
  • Administration Administer no faster than 25
    mg/min or in concentrations greater than 25
    mg/ml, inject deep IM into large muscle, dont
    give subcutaneously
  • Adverse reactions confusion, disorientation,
    fatigue, drowsiness, sedation, dizziness,
    extrapyramidal reactions, insomnia, nervousness,
    neuroleptic malignant syndrome, hypertension,
    hypotension, brady tachycardia, blurred vision,
    tinnitus, constipation, dry mouth, blood
    dyscrasias, respiratory depression, rash

33
Phenergan, cont.
  • Interactions
  • Drug-drug additive anticholinergic effects with
    anticholinergics CNS depressants additive CNS
    depression Epinephrine reversal of epis
    vasopressor effects MAO inhibitors increased
    extrapyramidal effects
  • Drug-diagnostic tests increased glucose levels,
    false positive or negative pregnancy tests, false
    negative skin allergan tests
  • Drug-herbsevening primrose- increased risk
    seizures, kava- increased risk adverse drug
    reactions
  • Drug-behavior additive CNS depression with
    alcohol, increased risk photosensitivity with sun
    exposure

34
Robinul (glycopyrrolate)
  • Class anticholinergic, antispasmodic,
    antimuscarinic, parasympatholytic
  • Action inhibits action of acetylcholine on
    muscarinic receptors that mediate effects of
    parasympathetic postganglionic impulses. This
    inhibition relaxes cardiac smooth muscle,
    inhibits vagal reflexes, and decreases tracheal
    and bronchial secretions

35
Robinul, cont.
  • Availability
  • IV 0.2 mg/ml
  • Tablets 1 mg, 2 mg

36
Robinul, cont.
  • Indications and dosage adjunct in peptic ulcer
    disorders, to diminish secretions and block
    cardiac vagal reflexes before or during surgery,
    to diminish or block cholinergic effects caused
    by anticholinesterase
  • 1 mg PO tid to max 8 mg/day OR 0.1-0.2 mg IM or
    IV tid to qid

37
Robinul, cont.
  • Off label uses sweating
  • Contraindications hypersensitivity to drug,
    arrhythmias, COPD, GI disease, infection, atony,
    or ileus, myasthenia gravis, glaucoma,
    obstructive uropathy, severe prostatic
    hypertrophy
  • Precautions cardiovascular disease, heart
    failure, hypertension, renal or hepatic disease,
    Down syndrome, hyperthyroidism, hiatal hernia,
    ulcerative colitis, mild to moderate BPH,
    autonomic heuropathy, spasticity, suspected brain
    damage, pregnant or breastfeeding patients

38
Robinul, cont.
  • Administration give oral dose 30-60 minutes
    before meals
  • IV administration either undiluted or diluted
    with D5W or saline, give each 0.2 mg over 1-2
    min.
  • Keep resuscitation equipment on hand to treat
    curare-like effects of overdose

39
Robinul, cont.
  • Adverse reactions weakness, nervousness,
    insomnia, drowsiness, dizziness, headache,
    confusion, excitement, palpitations, tachycardia,
    blurred vision, photophobia, mydriasis, increased
    intraocular pressure, cycloplegia, nausea,
    vomiting, constipation, abdominal distention,
    epigastric distress, heartburn, gastroesophageal
    reflux, dry mouth, paralytic ileus, urinary
    hesitancy or retention, lactation suppression,
    erectile dysfunction, urticaria, decreased
    sweating or anhidrosis, loss of taste, fever,
    allergic reaction, irritation at IM injection
    site, anaphylaxis, malignant hyperthermia

40
Robinul, cont.
  • Interactions increased anticholinergic effects
    with amantidine, antihistamines,
    antiparkinsonians, disopyramide, glutethimide,
    meperidine, phenothiazines, procainamide,
    quinidine, tircyclic antidepressants

41
Solumedrol (methylprednisolone sodium succinate)
  • Class glucocorticoid, antiasthmatic,
    anti-inflammatory (steroidal), immunosuppressant
  • Action reduces inflammation and prevents edema
    by stabilizing membranes and reducing
    permeability of leukocytic cells. Suppresses
    immune system by interfering with
    antigen-antibody interactions of macrophages and
    T cells

42
Solumedrol, cont.
  • Availability
  • Solution for IV/IM 40 mg, 125 mg, 500 mg, 1 g,
    2 g
  • Suspension for injection 20 mg/ml, 40 mg/ml, 80
    mg/ml
  • Tablets 2 mg, 4 mg, 8 mg, 16 mg, 24 mg, 32 mg

43
Solumedrol, cont.
  • Indications
  • diseases and disorders of endocrine system,
    collagen, skin, eye, GI, respiratory, or
    hematologic system, neoplastic diseases,
    allergies, multiple sclerosis, tuberculous
    meningitis, trichinosis, rheumatic disorders,
    osteoarthritis, bursitis, localized inflammatory
    lesions

44
Solumedrol, cont.
  • Dosages
  • 4-160 mg PO daily in four divided doses
    depending on disease or disorder
  • High dose therapy 30 mg/kg IV over at least 30
    min., may be repeated in 4-6 ours for 48 hours.

45
Solumedrol, cont.
  • Off label uses lupus nephritis, pneumocystis
    jiroveci pneumonia in AIDS patients
  • Contraindications hypersensitivity to drug or
    its component, systemic fungal infections

46
Solumedrol, cont.
  • Precautions cardiovascular, hepatic, renal, or
    GI disease. Active untreated infections,
    thromboembolic tendency, idiopathic
    thrombocytopenia purpura, osteoporosis,
    myasthenia gravis, hypothyroidism, glaucoma,
    ocular herpes simplex, vaccinia or varicella,
    seizure disorders, metastatic cancer, pregnant or
    breastfeeding patients, children

47
Solumedrol, cont.
  • Give prophylactic antacids in patients receiving
    high doses to prevent peptic ulcers
  • Methylprednisilone acetate is not for IV use- IM,
    intra-articular, intralesional or soft tissue
    injection
  • Methylprednisilone sodium succinate is for IV or
    IM use
  • For IV use, inject 500 mg dose over 2 to 3 min
    or more

48
Solumedrol, cont.
  • Adverse reactions headache, restlessness,
    nervousness, depression, euphoria, personality
    changes, psychoses, vertigo, paresthesias,
    insomnia, adhesive arachnoiditis, conus
    medullarus syndrome, increased intracranial
    pressure, seizures, meningitis, hypotension,
    hypertension, arrhythmias, heart failure, shock,
    fat embolism, thrombophlebitis, thromboembolism,
    cataracts, glaucoma, increased intraoccular
    pressure, nasal irritation, nasal septum
    perforation, sneezing, epistaxis, nasopharyngeal
    or oropharyngeal fungal infection, dysphonia,
    hoarseness, throat irritation, nausea, vomiting,
    abdominal distention, rectal bleeding, dry mouth,
    anorexia, esophageal candidiasis, esophageal
    ulcer, peptic ulcer, pancreatitis, amenorrhea,
    irregular menses, cough, wheezing, bronchospasm,
    decreased growth, hyperglycemia, fluid retention,
    cushingoid state, hypothalamic-pituitary-adrenal
    suppresion, adrenal suppression, acute adrenal
    insufficiency, muscle wasting, tendon rupture,
    weakness, rash, pruritis, decreased wound
    healing, fragile skin, skin atrophy, bad taste,
    weight gain, etc.

49
Solumedrol, cont.
  • Interactions
  • Drug to drug amphotericin B, mezlocillin,
    piperacillin, thiazide and loop diuretics,
    ticarcillin- additive hypokalemai,
    fluoroquinolones- increased risk of tendon
    rupture, isoniazid, phenobarbital, phenytoin,
    rifampin- decreased

50
Valium
  • Diazepam
  • Action produces anxiolytic effect and CNS
    depression by stimulating gamma-amniobutyric acid
    receptors, relaxes skeletal muscles of the spine
    by inhibiting afferent pathways, controls
    seizures by enhancing presynaptic inhibition
  • Availability
  • Injection 5 mg/ml
  • Oral solution 1 mg/ml, 5 mg/5 ml
  • Rectal gel 2.5 mg, 10 mg, 15 mg, 20 mg
  • Tablets 2 mg, 5 mg, 10 mg

51
Valium, cont.
  • Indications anxiety disorders, before
    interventional procedures, status epilepticus and
    severe recurrent seizures, muscle spasm, acute
    alcohol withdrawal
  • Off label uses panic attacks, adjunct to general
    anesthesia
  • Contraindications hypersensitivity, other
    benzodiazepines, alcohol, or tartrazine, coma or
    CNS depression, narrow angle glaucoma

52
Valium, cont.
  • Dosages Adults 2-10 mg PO two to four times a
    day, 2-10 mg IV q3-4 hours, 5-15 mg IV
    pre-cardioversion or endoscopy
  • Precautions hepatic dysfunction, severe renal
    impairment, elderly patients, pregnant or
    breastfeeding patients, children
  • For IV administration administer slowly into
    large vein, rate of 1 minute per 5 mg in adults
    or at least 3 minutes for each 0.25 mg/kg in
    children
  • IV route preferred over IM route
  • Dont mix wit other meds or solutions in syringe
  • Enforce bed rest for 3 hours post-administration
  • Give deep IM and slowly into large muscle mass

53
Valium, cont.
  • Adverse reactions dizziness, drowsiness,
    lethargy, depression, light-headedness,
    disorientation, anger, manic or hypomanic
    episodes, restlessness, paresthesia, headache,
    slurred speech, dysarthria, stupor, tremor,
    dystonia, vivid dreams, extrapyrimidal reactions,
    mild paradoxical excitation, brady or
    tachycardia, hyper or hypotension, palpitations,
    cardiovascular collapse, blurred vision,
    diplopia, nystagmus, nasal congestion, nausea,
    vomiting, diarrhea, constipation, gastric
    disorders, difficulty swallowing, increased
    salivation, urinary retention or incontinence,
    menstrual irregularities, gynecomastia, libido
    changes, blood dyscrasias, hepatic dysfunction,
    muscle rigidity, dermatitis, rash, pruritus,
    diaphoresis, weight gain or loss, decreased
    appetite, edema, hiccups, fever, dependence

54
Valium, cont.
  • Interactions
  • Drug-drug additive effects with
    antidepressants, antihistamines, barbiturates,
    opioids decreased levels with numerous drugs-
    check ddrug references, increased dig levels,
    decreased levodopa levels
  • Drug-diagnostic tests increased levels of liver
    enzymes, decreased platelet counts
  • Drug-behavior increased CNS depression with
    alcohol

55
Valium, cont.
  • Patient monitoring vital signs and neuro status,
    supervise ambulation especially in elderly,
    monitor cbc, renal, and liver enzymes
  • Avoid sudden drug withdrawal, taper gradually to
    termination of therapy

56
Questions
  • How fast are each of the following meds pushed?
  • 1. solumedrol
  • 2. decadron
  • 3. robinal
  • 4. digoxin
  • 5. valium
  • 6. phenergan

57
Answer
  • SLOW IV PUSH

58
Questions
  • Which medication may only be push for maintenance
    purposes only? Meaning if this is the initial
    administration of this drug to establish a
    therapeutic value, the LPN may not push it.

59
Answer
  • Digoxin

60
Questions
  • Which drug must be diluted in 10 ml normal
    saline, pushed through the port farthest from the
    patient over several minutes?

61
Answer
  • Phenergan

62
Questions
  • Which drug has an off label use for panic attacks
    but is commonly used pre-procedurally for
    endoscopy and cardioversion?

63
Answer
  • Valium

64
Questions
  • Which two things must be verified before bar
    coding the patient in preparation for drug
    administration every time?

65
Answer
  • Patients correct name and date of birth, no
    nicknames

66
Questions
  • What are the five rights to drug administration
    that the prudent nurse checks EVERY time a
    medication is administered?

67
Answer
  • Right patient
  • Right drug
  • Right dose
  • Right route
  • Right time

68
Medication Checklist
  • Please obtain a copy of the Medication 2
    Checklist from your Nurse Manager.
  • You must complete IV administration of three
    different medications. One of those three
    medications must be phenergan and you must be
    directly observed administering phenergan on 3
    separate occasions.
Write a Comment
User Comments (0)
About PowerShow.com